Tag Archives: The Stem Cell Blog

Kansas Stem Cell Center Close To First Clinical Trial – KMUW

Continue reading

2017-03-09 NEWS

KMUW

Kansas Stem Cell Center Close To First Clinical Trial
KMUW
Buddhadeb Dawn, right, executive director of the Midwest Stem Cell Therapy Center, talks with Rep. Les Osterman, far left, and David Prentice, center, of Charlotte Lozier Institute. Dawn provided an update on the center’s research Tuesday in Topeka.
KCK stem cell center nears first clinical trialKansas City Business Journal
Upcoming Stem Cell Drive: You Could Save a LifeBrock Press
Greg Knutson Joins US Stem Cell, Inc.’s Board of DirectorsYahoo Finance
Medgadget (blog) –Digital Journal –Satellite PR News (press release)
all 31 news articles »
Continue reading

2017-03-09 NEWS

Phys.Org

Immunotherapy trial cures Tasmanian devils of DFTD
Phys.Org
Professor Greg Woods, the leader of the DFTD team at Menzies, said scientists used immunotherapy on devils with a golf-ball sized tumours and then observed the tumours gradually shrinking and disappearing over three months. “This is almost a Eureka …
Cure hope for Tasmanian devils plagued by facial tumoursThe Mercury
Tasmanian devils get new hope against DFTD9news.com.au
Tasmanian devils helped to fight off facial tumour disease with live cancer cell injectionABC Online

all 6 news articles »

Continue reading

2017-03-09 NEWS

Curetoday.com

Immunotherapy Is Moving Forward in Bladder and Other GU Cancers
Curetoday.com
In prostate cancer, we are very excited to try some trials for men who have rising PSA after surgery and to give immunotherapy either alone or with hormonal therapy to try to reset their whole course of disease. We’re seeing this in kidney cancer and

Continue reading

2017-03-09 NEWS

Curetoday.com

Immunotherapy Is Moving Forward in Bladder and Other GU Cancers
Curetoday.com
In prostate cancer, we are very excited to try some trials for men who have rising PSA after surgery and to give immunotherapy either alone or with hormonal therapy to try to reset their whole course of disease. We’re seeing this in kidney cancer and